Cardio Diagnostics Holdings, Inc.
Cardio Diagnostics Holdings, Inc. (CDIO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CDIO · as of Jun 9, 2026
Key Statistics
Explore Cardio Diagnostics Holdings, Inc. Data
cdio stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
cdio competitorsCDIO
ADIL
ADXN
BCDA
BCLI
CELZStock Performance
Full HistoryAbout Cardio Diagnostics Holdings, Inc.
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key…
what is cardio diagnostics holdings, inc. · cdio stock overview · cardio diagnostics holdings, inc. company profile · who is cardio diagnostics holdings, inc. ceo · cdio NASDAQ · cardio diagnostics holdings, inc. headquarters · cardio diagnostics holdings, inc. business segments
About Stock Overview & Key Data
Cardio Diagnostics Holdings, Inc. (CDIO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 14, 2022. As of the latest trading session, CDIO stock price is $1.99, with a market capitalization of $4.1M. The stock has returned -58.88% over the past 12 months and -26.57% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Cardio Diagnostics Holdings, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Cardio Diagnostics Holdings, Inc. reported revenue of $14825.00 and net income of -$6.5M. For detailed data — including Cardio Diagnostics Holdings, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cardio Diagnostics Holdings, Inc. (CDIO) stock price is $1.99. The stock is traded on NASDAQ under the ticker symbol CDIO. The 52-week range is $0.97 – $7.91.